Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer
Go back to Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer| (NASDAQ: XLO) | Delayed: 9.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.01 | 52 Week High | $ | |||
| Open | $9.01 | 52 Week Low | $ | |||
| Day High | $9.01 | P/E | N/A | |||
| Day Low | $9.01 | EPS | $ | |||
| Volume | 88,188 | |||||



